233 related articles for article (PubMed ID: 9825732)
1. Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic gamma-aminobutyric acid (GABA) inputs.
de Miguel R; Romero J; Muñoz RM; García-Gil L; González S; Villanua MA; Makriyannis A; Ramos JA; Fernández-Ruiz JJ
Biochem Pharmacol; 1998 Nov; 56(10):1331-8. PubMed ID: 9825732
[TBL] [Abstract][Full Text] [Related]
2. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.
Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA
Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167
[TBL] [Abstract][Full Text] [Related]
3. Effects of delta9-THC on VIP-induced prolactin secretion in anterior pituitary cultures: evidence for the presence of functional cannabinoid CB1 receptors in pituitary cells.
Rodríguez de Fonseca F; Wenger T; Navarro M; Murphy LL
Brain Res; 1999 Sep; 841(1-2):114-22. PubMed ID: 10546994
[TBL] [Abstract][Full Text] [Related]
4. Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol.
Romero J; Berrendero F; Manzanares J; Pérez A; Corchero J; Fuentes JA; Fernández-Ruiz JJ; Ramos JA
Synapse; 1998 Nov; 30(3):298-308. PubMed ID: 9776133
[TBL] [Abstract][Full Text] [Related]
5. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.
Romero J; Garcia-Palomero E; Castro JG; Garcia-Gil L; Ramos JA; Fernandez-Ruiz JJ
Brain Res Mol Brain Res; 1997 Jun; 46(1-2):100-8. PubMed ID: 9191083
[TBL] [Abstract][Full Text] [Related]
6. Role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors in the control of prolactin, growth hormone and gonadotropin secretion in prepubertal rats.
González LC; Pinilla L; Tena-Sempere M; Aguilar E
J Endocrinol; 1999 Sep; 162(3):417-24. PubMed ID: 10467233
[TBL] [Abstract][Full Text] [Related]
7. Perinatal delta(9)-tetrahydrocannabinol exposure alters the responsiveness of hypothalamic dopaminergic neurons to dopamine-acting drugs in adult rats.
García-Gil L; De Miguel R; Muñoz RM; Cebeira M; Villanua MA; Ramos JA; Fernández-Ruiz JJ
Neurotoxicol Teratol; 1997; 19(6):477-87. PubMed ID: 9392783
[TBL] [Abstract][Full Text] [Related]
8. The effect of anandamide on prolactin secretion is modulated by estrogen.
Scorticati C; Mohn C; De Laurentiis A; Vissio P; Fernández Solari J; Seilicovich A; McCann SM; Rettori V
Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2134-9. PubMed ID: 12578974
[TBL] [Abstract][Full Text] [Related]
9. Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat.
Murphy LL; Steger RW; Smith MS; Bartke A
Neuroendocrinology; 1990 Oct; 52(4):316-21. PubMed ID: 1979838
[TBL] [Abstract][Full Text] [Related]
10. Ontogenic modifications in the effect of the GABAergic system on the hypothalamic excitatory amino acids: its relationship with GABAergic control of gonadotrophin secretion during sexual maturation in female rats.
Carbone S; Ponzo O; Szwarcfarb B; Rondina D; Reynoso R; Scacchi P; Alberto Moguilevsky J
Brain Res Dev Brain Res; 2002 Jan; 133(1):13-8. PubMed ID: 11850059
[TBL] [Abstract][Full Text] [Related]
11. Estriol affects prolactin and LH secretion in rats.
Diaz MC; Seilicovich A; Duvilanski BH; Siseles N; Lasaga M; Debeljuk L
J Endocrinol Invest; 1989 Jan; 12(1):1-7. PubMed ID: 2501380
[TBL] [Abstract][Full Text] [Related]
12. Identification of endocannabinoids and cannabinoid CB(1) receptor mRNA in the pituitary gland.
González S; Manzanares J; Berrendero F; Wenger T; Corchero J; Bisogno T; Romero J; Fuentes JA; Di Marzo V; Ramos JA; Fernández-Ruiz J
Neuroendocrinology; 1999 Aug; 70(2):137-45. PubMed ID: 10461028
[TBL] [Abstract][Full Text] [Related]
13. Hypothalamic Prolactin Regulation of Luteinizing Hormone Secretion in the Female Rat.
Grachev P; Li XF; Goffin V; O'Byrne KT
Endocrinology; 2015 Aug; 156(8):2880-92. PubMed ID: 25993525
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPgammaS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide.
Romero J; Berrendero F; García-Gil L; Lin SY; Makriyannis A; Ramos JA; Fernández-Ruiz JJ
Neurochem Int; 1999 Jun; 34(6):473-82. PubMed ID: 10402222
[TBL] [Abstract][Full Text] [Related]
15. Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland.
González S; Bisogno T; Wenger T; Manzanares J; Milone A; Berrendero F; Di Marzo V; Ramos JA; Fernández-Ruiz JJ
Biochem Biophys Res Commun; 2000 Apr; 270(1):260-6. PubMed ID: 10733937
[TBL] [Abstract][Full Text] [Related]
16. Gamma amino butyric acid (GABA) controls anterior pituitary hormone secretion.
McCann SM; Rettori V
Adv Biochem Psychopharmacol; 1986; 42():173-89. PubMed ID: 3020896
[TBL] [Abstract][Full Text] [Related]
17. Gamma aminobutyric acid (GABA), a modulator of anterior pituitary hormone secretion by hypothalamic and pituitary action.
McCann SM; Vijayan E; Negro-Vilar A; Mizunuma H; Mangat H
Psychoneuroendocrinology; 1984; 9(2):97-106. PubMed ID: 6089244
[TBL] [Abstract][Full Text] [Related]
18. Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats.
Garcia-Gil L; de Miguel R; Romero J; Perez A; Ramos JA; Fernández-Ruiz JJ
Neurotoxicol Teratol; 1999; 21(3):277-83. PubMed ID: 10386831
[TBL] [Abstract][Full Text] [Related]
19. Prolactin- and testosterone-induced inhibition of LH secretion after orchidectomy: role of preoptic and tuberoinfundibular gamma-aminobutyric acidergic neurones.
Grattan DR; Selmanoff M
J Endocrinol; 1994 Oct; 143(1):165-74. PubMed ID: 7964315
[TBL] [Abstract][Full Text] [Related]
20. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J
Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]